Article ID Journal Published Year Pages File Type
2576011 The American Journal of Geriatric Pharmacotherapy 2008 12 Pages PDF
Abstract
Conclusions: Darbepoetin alfa administered QM maintained Hb levels ≥11 g/dL in patients with CKD (not on dialysis) aged <65, 65 to 74, and ≥75 years. This treatment regimen may help optimize anemia management for older community-dwelling and long-term care patients.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Geriatrics and Gerontology
Preview
Effect of darbepoetin alfa administered once monthly on maintaining hemoglobin levels in older patients with chronic kidney disease
Authors
, , , , ,